315 related articles for article (PubMed ID: 34356618)
1. Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease.
Lee NT; Ong LK; Gyawali P; Nassir CMNCM; Mustapha M; Nandurkar HH; Sashindranath M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356618
[TBL] [Abstract][Full Text] [Related]
2. CD39: Interface between vascular thrombosis and inflammation.
Kanthi YM; Sutton NR; Pinsky DJ
Curr Atheroscler Rep; 2014 Jul; 16(7):425. PubMed ID: 24838375
[TBL] [Abstract][Full Text] [Related]
3. Development of endothelial-targeted CD39 as a therapy for ischemic stroke.
Lee NT; Savvidou I; Selan C; Calvello I; Vuong A; Wright DK; Brkljaca R; Willcox A; Chia JSJ; Wang X; Peter K; Robson SC; Medcalf RL; Nandurkar HH; Sashindranath M
J Thromb Haemost; 2024 May; ():. PubMed ID: 38754782
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
5. Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia/reperfusion injury.
Zhang X; Gong P; Zhao Y; Wan T; Yuan K; Xiong Y; Wu M; Zha M; Li Y; Jiang T; Liu X; Ye R; Xie Y; Xu G
EBioMedicine; 2022 Oct; 84():104275. PubMed ID: 36152520
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
[TBL] [Abstract][Full Text] [Related]
7. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
9. Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.
Cui M; Ding H; Chen F; Zhao Y; Yang Q; Dong Q
Mol Neurobiol; 2016 Jan; 53(1):240-253. PubMed ID: 25428621
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-targeted overexpression of Krüppel-like factor 11 protects the blood-brain barrier function after ischemic brain injury.
Zhang X; Tang X; Ma F; Fan Y; Sun P; Zhu T; Zhang J; Hamblin MH; Chen YE; Yin KJ
Brain Pathol; 2020 Jul; 30(4):746-765. PubMed ID: 32196819
[TBL] [Abstract][Full Text] [Related]
11. Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke.
Li YJ; Shi SX; Liu Q; Shi FD; Gonzales RJ
Neurosci Lett; 2020 Sep; 735():135160. PubMed ID: 32561451
[TBL] [Abstract][Full Text] [Related]
12. KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke.
Zhang X; Wang L; Han Z; Dong J; Pang D; Fu Y; Li L
J Neuroinflammation; 2020 Apr; 17(1):107. PubMed ID: 32264912
[TBL] [Abstract][Full Text] [Related]
13. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules.
Fuentes E; Palomo I
Vascul Pharmacol; 2015 Dec; 75():1-6. PubMed ID: 25989108
[TBL] [Abstract][Full Text] [Related]
15. The role of the ATP-adenosine axis in ischemic stroke.
Schädlich IS; Winzer R; Stabernack J; Tolosa E; Magnus T; Rissiek B
Semin Immunopathol; 2023 May; 45(3):347-365. PubMed ID: 36917241
[TBL] [Abstract][Full Text] [Related]
16. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells.
Imai M; Kaczmarek E; Koziak K; Sévigny J; Goepfert C; Guckelberger O; Csizmadia E; Schulte Am Esch J; Robson SC
Biochemistry; 1999 Oct; 38(41):13473-9. PubMed ID: 10521254
[TBL] [Abstract][Full Text] [Related]
17. Ectonucleotidases in Intestinal and Hepatic Inflammation.
Vuerich M; Robson SC; Longhi MS
Front Immunol; 2019; 10():507. PubMed ID: 30941139
[TBL] [Abstract][Full Text] [Related]
18. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
19. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
20. Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies.
Patwa J; Flora SJS
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
